Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Hurh
E. Hurh
Ovarian cancer
Pathology
Medicine
Oncology
Pharmacodynamics
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase Ib study of AMG 386 combined with either pegylated liposomal doxorubicin (PLD) or topotecan (T) in patients with advanced ovarian cancer.
2010
Journal of Clinical Oncology
Robert M. Wenham
Joseph W. Leach
Sidney A. Scudder
B. R. Amin
Charles H. Pippitt
Alan N. Gordon
Nuwan Nanayakkara
E. Hurh
Daniel E. Stepan
Russell J. Schilder
Show All
Source
Cite
Save
Citations (5)
Exposure-response relationships of AMG 386 in combination with weekly paclitaxel in advanced ovarian cancer: Population pharmacokinetic/pharmacodynamic (PK/PD) modeling to facilitate phase III dose selection.
2010
Journal of Clinical Oncology
Jian-Feng Lu
Erik Rasmussen
Lynn Navale
Mita Kuchimanchi
E. Hurh
Beth Y. Karlan
Ignace Vergote
Daniel E. Stepan
David M. Weinreich
Yu-Nien Sun
Show All
Source
Cite
Save
Citations (7)
1